Tci Wealth Advisors, Inc. Chimerix Inc Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$1.67 - $2.35 $334 - $470	-200 Reduced 33.33%	400 $0
Q1 2022 Apr 29, 2022	SELL	$4.58 - $6.8 $3,100 - $4,603	-677 Reduced 53.01%	600 $3,000
Q4 2021 Jan 24, 2022	BUY	$5.23 - $7.18 $4,586 - $6,296	877 Added 219.25%	1,277 $8,000
Q3 2021 Oct 29, 2021	BUY	$5.94 - $8.75 $1,188 - $1,750	200 Added 100.0%	400 $2,000
Q2 2021 Aug 02, 2021	BUY	$7.54 - $9.79 $754 - $978	100 Added 100.0%	200 $2,000
Q1 2021 Apr 29, 2021	BUY	$4.76 - $11.25 $476 - $1,125	100 New	100 $1,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.